Clinical Trial

Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA

Withdrawn Phase 3
View on ClinicalTrials.gov →
Why the trial stopped
The registration of this research plan was incorrect. A new registration has been re-applied for.
Summary
This study aimed to compare the efficacy and safety of enarodustat combined with cyclosporine versus cyclosporine alone in the treatment of TD-NSAA.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Withdrawn 2026-06-05
critical Reason stopped changed: — → The registration of this research plan was incorrect. A new registration has been re-applied for. 2026-06-05
notable Enrollment reduced: 90 -> 0 participants 2026-06-05
Trial Details
NCT Number NCT07522996
Lead Sponsor Peking Union Medical College Hospital
Conditions Transfusion-dependent Non-severe Aplastic Anemia
Start Date 2026-06
Primary Completion 2028-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-04